Ethics/Regulatory

European Medicines Agency, EUnetHTA publish joint work plan

Wednesday, November 20, 2013 12:47 PM

The European Medicines Agency (EMA) and EUnetHTA, the European network for Health Technology Assessment, have published a joint three-year work plan outlining key areas of collaboration.

More... »


MHRA, BIA call for earlier access to medicines in the U.K.

Monday, November 18, 2013 01:39 PM

Following the publication of the report on innovation in the regulation of healthcare by the Medicines and Healthcare Products Regulatory Agency (MHRA), the BioIndustry Association (BIA) urges the U.K. government to implement a properly funded and reimbursed Earlier Access to medicines Scheme (EAS), which the group makes its number one recommendation.

More... »

Subscribe to The CenterWatch Monthly

Pfizer responds to U.K. pharma pricing deal

Wednesday, November 6, 2013 12:43 PM

Pfizer released a statement calling the new Pharmaceutical Price Regulation Scheme (PPRS), agreed to by the U.K. government and industry, a missed opportunity for British patients, the U.K. economy and industry.

More... »

FDA approves first medicine with Breakthrough Therapy designation

Monday, November 4, 2013 01:35 PM

Genentech, a member of the Roche Group, has announced that the FDA approved Gazyva (obinutuzumab), also known as GA101, in combination with chlorambucil chemotherapy for the treatment of people with previously untreated chronic lymphocytic leukemia (CLL).

More... »

FDA takes two actions on drug shortages

Friday, November 1, 2013 11:14 AM

The FDA is taking two actions to further enhance its ongoing efforts to prevent and resolve drug shortages, a significant public health threat that can delay, and in some cases even deny, critical care for patients. Following the President’s 2011 Executive Order to reduce drug shortages, the number of new shortages in 2012 fell to 117, down from 251 in 2011. 

More... »

NHS fears changing data protection rules could erode quality of research in U.K.

Friday, October 25, 2013 11:48 AM

The NHS European office and the Royal College of Physicians have warned a new Europe-wide law on data protection could have a negative impact on healthcare provision and erode the quality and effectiveness of health research in the U.K.

More... »

FDA awards 15 grants to stimulate drug, device development for rare diseases

Wednesday, October 23, 2013 02:36 PM

The FDA has awarded 15 grants totaling more than $14 million to boost the development of products for patients with rare diseases.

More... »

Article: Change common rule to increase minority voices in research

Monday, October 21, 2013 02:08 PM

An article to be published in the American Journal of Public Health recommends changing the federal regulations that govern research oversight to address continued underrepresentation of minorities in research studies.

More... »

Sanofi, Merck participate in pilot for rapid European health technology assessment

Friday, October 18, 2013 11:06 AM

Sanofi Pasteur MSD is the first vaccine company to have successfully participated in a pilot testing a new rapid relative effectiveness assessment of health technologies in Europe.

More... »

FDA staff returns to work

Friday, October 18, 2013 09:02 AM

A message on the FDA website from Health and Human Service secretary Katheleen Sebelius thanked readers for their patience throughout the lapse in Federal funding. She said, “The uncertainty of the past few weeks has created many difficult situations, and the shutdown has imposed hardships on many employees as well as the public we serve.”

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 15

Cancer Treatment Centers of America chooses WCG as its exclusive IRB, sheds five local hospital IRBs

Five southern research groups form public-private network to help save time, money for clients with early-stage biologics

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs